Clinicopathological Significance of SMAD4 Expression in Breast Canceropen access
- Authors
- Woo, Jun-Seok; Chung, Min Sung; Paik, Seung Sam
- Issue Date
- Dec-2019
- Publisher
- 한국유방암학회
- Keywords
- Breast neoplasms; Prognosis; SMAD4 protein; Transforming growth factor beta
- Citation
- Journal of Breast Disease, v.7, no.2, pp.52 - 58
- Indexed
- KCI
- Journal Title
- Journal of Breast Disease
- Volume
- 7
- Number
- 2
- Start Page
- 52
- End Page
- 58
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/146568
- DOI
- 10.14449/jbd.2019.7.2.52
- ISSN
- 2288-5560
- Abstract
- Purpose: SMAD4 is a member of the SMAD family and acts as a central mediator of transforming growth factor beta signaling. Little is known about SMAD4 expression and its prognostic significance in breast cancer. We evaluated the clinicopathological and prognostic significance of SMAD4 expression in breast cancer. Methods: Two hundred and fifty-five patients with invasive ductal carcinoma of the breast from 2000 to 2008 were retrospectively analyzed. We investigated SMAD4 expression using a tissue microarray-based immunohistochemical assay and evaluated the association between SMAD4 and prognosis of breast cancer. Results: High SMAD4 expression was positively associated with early stage (p=0.009), estrogen receptor positivity (p=0.026), and human epidermal growth factor receptor 2 negativity (p=0.001). A significant difference in overall survival (OS) was associated with high SMAD4 expression in patients with T1 stage tumors (hazard ratio: 0.459, p=0.024). Conclusion: High SMAD4 expression was correlated with several favorable prognostic factors and was associated with favorable OS in T1 stage breast cancer. SMAD4 in breast cancer has potential prognostic significance, and further investigations and understanding about SMAD4 expression are needed.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 외과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/146568)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.